Skip to main content

United States News All stories

Every story in this section, newest first — page 377 of 389.

Grafa
Health

Agenus combination therapy shows durable response in refractory ovarian cancer

Agenus (NASDAQ:AGEN) has published peer-reviewed results from the ovarian cancer cohort of its Phase 1b trial in The Journal for ImmunoTherapy of Cancer (JITC), highlighting a potential breakthrough for a patient population with historically limited options.

Read more: Agenus combination therapy shows durable response in refractory ovarian cancer
Grafa
Health

Novo Nordisk wins FDA nod for Wegovy pill, prepares $149 cash-pay launch

Novo Nordisk A/S (NASDAQ:NVO) received U.S. Food and Drug Administration approval on Monday for the first oral version of its blockbuster weight-loss medication Wegovy, setting the stage for a January launch that will bypass traditional insurance hurdles

Read more: Novo Nordisk wins FDA nod for Wegovy pill, prepares $149 cash-pay launch